(Q34150300)

English

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kenneth Dickstein

1

object named as

Kenneth Dickstein

0 references

2

object named as

John Kjekshus

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

OPTIMAAL Steering Committee of the OPTIMAAL Study Group

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

360

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9335

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

752-760

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909895-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)09895-1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34150300&oldid=1962669060"